Dental Care Clinics in Edgartown, MA Accepting Medicare
2 Dental Care Clinics found. Showing 1 - 2
 Main Street Dental Dentist Medicare: Not Enrolled in Medicare Practice Location: 207 Upper Main St, Edgartown, MA 02539 Phone: 508-939-9000 Fax: 508-939-8537 |
Edgartown Dental Group Llc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 207 Upper Main St, Edgartown, MA 02539 Phone: 508-939-9000 |
News Archive
Gene mutations responsible for causing cataracts in children, identified
Gene mutations responsible for causing cataracts in children have been identified by a team of University of Utah vision researchers. The discovery was reported in a recent issue of The Journal of Medical Genetics.
Microplasmin MIVI-TRUST Phase III program's positive pooled results presented at EURETINA
ThromboGenics NV, a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, cardiovascular disease and cancer, announces that the pooled results from the successful microplasmin MIVI-TRUST Phase III program were presented today at the EURETINA (European Society of Retina Specialists) Congress in Paris, France.
Diabetes patients experiencing empathy from PCPs have beneficial long-term clinical outcomes
A United Kingdom study designed to examine the association between primary care practitioner empathy and incidence of cardiovascular disease and all-cause mortality among type 2 diabetes patients found that those patients experiencing greater empathy in the year following their diagnosis saw beneficial long-term clinical outcomes.
Characterization of Cajal-Retzius cells during development in mouse model of Alzheimer's disease
Cajal-Retzius cells are reelin-secreting neurons in the marginal zone of the neocortex and hippocampus.
AstraZeneca Chief Scientist shares enthusiasm for collaborative clinical research
The pharmaceutical industry must ensure an improved record of delivery by providing high quality, cost effective solutions to well defined unmet needs. This can be achieved through strategic collaborations that strengthen disease knowledge and provide improved tools to strengthen therapeutic target validation and to monitor therapeutic efficacy, says Andy Dray, Chief Scientist at AstraZeneca.
› Verified 3 days ago